[1]
Cecchi, E. et al. 2017. Cystatin C, but not urinary or serum NGAL, may be associated with contrast induced nephropathy after percutaneous coronary invasive procedures: A single center experience on a limited number of patients. Acta Medica Academica. 46, 1 (Jun. 2017), 34–43. DOI:https://doi.org/10.5644/ama2006-124.184.